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Background: Infections, mostly those associated with colonization of wound by different
pathogenic microorganisms, are one of the most serious health complications during a
medical treatment. Therefore, this study is focused on the isolation, characterization, and
identiﬁcation of microorganisms prevalent in superﬁcial wounds of patients (n = 50) pre-
senting with bacterial infection.
Methods: After successful cultivation, bacteria were processed and analyzed. Initially
the  identiﬁcation of the strains was performed through matrix-assisted laser desorp-
tion/ionization time-of-ﬂight mass spectrometry based on comparison of protein proﬁles
(2–30  kDa) with database. Subsequently, bacterial strains from infected wounds were iden-
tiﬁed  by both matrix-assisted laser desorption/ionization time-of-ﬂight mass spectrometry
and sequencing of 16S rRNA gene 108.
Results: The most prevalent species was Staphylococcus aureus (70%), and out of those 11%turned out to be methicillin-resistant (mecA positive). Identiﬁed strains were compared withpatients’ diagnoses using the method of artiﬁcial neuronal network to assess the associa-
tion between severity of infection and wound microbiome species composition. Artiﬁcial
neuronal network was subsequently used to predict patients’ prognosis (n = 9) with 85%
success.
∗ Corresponding author.
E-mail address: kizek@sci.muni.cz (R. Kizek).
http://dx.doi.org/10.1016/j.bjid.2015.08.013
1413-8670/© 2015 Elsevier Editora Ltda. All rights reserved.
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Conclusions: In all of 50 patients tested bacterial infections were identiﬁed. Based on the
proposed artiﬁcial neuronal network we were able to predict the severity of the infection
and length of the treatment.
© 2015 Elsevier Editora Ltda. All rights reserved.
I
S
u
b
o
i
u
r
c
W
l
p
s
t
p
b
c
i
a
h
m
m
A
i
t
w
t
i
a
f
p
t
s
h
n
s
g
i
o
l
l
r
s
r
m
g
antroduction
kin has an important role in preventing the entry of
ndesirable substances, organisms, and bacteria into the
loodstream.1,2 Loss of skin integrity leads to different types
f wounds which have the humidity, warmth, and a nurtur-
ng environment ideal for colonization and proliferation of
ndesirable bacterial strains, changing the naturally occur-
ing microbiome. Colonized sites are usually polymicrobial, i.e.
ontain more  than one bacterium with pathogenic potential.3
ound infections are marked by disturbed host–bacteria equi-
ibrium in a traumatized tissue environment favoring the
athogenic bacteria. A wound infection not only has the pos-
ibility to elicit a systemic response (sepsis), but is also able
o inhibit the multiple processes involved in the orchestrated
rogression of normal wound healing.4
The concept of microbiome was ﬁrst suggested in 2001
y Lederberg and McCray and was described as an ecological
ohort of commensal, symbiotic, and pathogenic microorgan-
sms sharing a body space.5 Previously, it was estimated that
s much as 20 to 60% of human-associated microbiome is
ard-to-identify, which has likely resulted in an underesti-
ation of microbiome diversity.6 One of the most frequent
icroorganisms in infected wound is Staphylococcus aureus.7–10
ccording to numerous studies,11–13 another common organ-
sm in infected wounds is Pseudomonas aeruginosa with up
o 10% occurrence, causing nosocomial infections together
ith S. aureus and other bacteria. In addition, the Enterobac-
eriaceae family is most often identiﬁed in connection with
mmunocompromised patients or those who have undergone
bdominal surgery.1
Bacterial infections, increasingly occurring in medical
acilities, can seriously complicate the outcome of treated
atients.14,15 This is particularly connected with rising resis-
ance of bacterial strains toward antibiotics or metals,16,17 thus
igniﬁcantly hindering treatment success. Although being
ighly debated the mechanism of resistance development has
ot been satisfactorily elucidated.18–21
The elevated occurrence of resistant bacterial strains is
trictly linked with increased utilization of invasive sur-
ical techniques, which are often performed in elderly,
mmunocompromised patients. Simultaneously, with the use
f antibiotics, bacterial resistance can evolve in surgical sites,
eading to bacteremia and sepsis, and thus signiﬁcantly pro-
onging the healing phase of a patient. Although bacterial
esistance presents a problem in healthcare facilities, there
till exist few possibilities to eliminate the most frequent
esistant strains that cause hospital-acquired infection –
ethicillin-resistant S. aureus (MRSA),22,23 e.g. highly potent
lycopeptide vancomycin.24 However, for a correct choice of
ntibiotics one needs to accurately identify the microbiomecomposition of infected wounds. Knowledge of the bacterial
ecology of wounds may thus lead to increase treatment suc-
cess, coupled with curbing bacterial resistance as a result of
inadequate utilization of antibiotics.25–28
Accordingly, this work is focused on identiﬁcation of the
microbiome associated with serious infections in hard-to-heal
wounds with the aim to propose a prediction model, com-
prising both the microbiome composition and patientsh´ealth
conditions.
Materials  and  methods
Chemicals,  preparation  of  deionized  water  and  pH
measurement
Chemicals used in this study were acquired from Sigma-
Aldrich (St. Louis, MO, USA) in ACS purity unless noted
otherwise. Deionized water was prepared using reverse osmo-
sis equipment Aqual 25 (Aqual s.r.o., Brno, Czech Republic) and
further puriﬁed using Milli-Q Direct QUV equipped with the UV
lamp, with 18 M resistance. pH was measured using the pH
meter WTW  inoLab (Weilheim, Germany).
Preparation  of  hospital  samples  and  their  cultivation
Cohort  of  patients  with  bacterial  infections
For evaluation, patients with superﬁcial or deep wounds were
selected according to infection severity. Detailed informa-
tion concerning the patients is documented in S1. A total
of 50 patients aged 19 through 93 years were enrolled into
the clinical study, and 13 patients were 70–79 years old; 23
patients superﬁcial wounds and 27 deep wounds. For all
patients, the treatment duration was determined by the trau-
matologist based severity and extent of infection, associated
diseases potentially interfering with treatment outcome and
healing of wounds, and other factors such as patient age,
concomitant medications, and previous medical history. For
conﬁrmation of the functionality of the neural network 9
blank samples from 9 patients identiﬁed by MALDI-TOF MS
were used. Enrollment of patients into the clinical study
was approved by the Ethics Committee of Trauma hospital
in Brno.
Collection  of  wound  swabs  from  patients  with  bacterial
infections
The smears, collected from infected wounds with the agree-
ment of patients, were sampled by rolling motion at the wound
using a sterile swab sampler. All patients were divided into
two subgroups, on the grounds of infection severity: deep and
superﬁcial wound. A detailed description of comorbidities and
duration of treatment was obtained. Patients were classiﬁed
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according to the Classiﬁcation of surgical wounds – SSI (sur-
gical site infections).29–31 Infected wounds were sampled by
using disposable tampon swabs maximizing collection of rep-
resentative microﬂora. Tampons were subsequently stored in
transport medium (inorganic salts, sodium thioglycolate, 1%
agar, activated charcoal). The important part of our work-
ﬂow process comprised sampling in duplicates with further
transport in both aerobic and anaerobic conditions to preserve
bacterial viability.
Cultivation  of  clinical  specimens
Four types of selective nutrient media (blood agar enriched by
10% NaCl, Endo agar, blood agar without any other compo-
nent, and blood agar with amikacin) we employed for further
microbiological selection. Petri dishes, containing the above
mentioned media were subsequently incubated according to
conventional protocols, as described elsewhere,32–35 to main-
tain suitable conditions for growth of all types of bacteria.
These Petri dishes were incubated for 24–48 h at 37 ◦C sup-
plemented by TGY medium (1 g L−1 glucose, 5 g L−1 tryptone,
2.5 g L−1 yeast extract). Subsequently, individual colonies were
collected from each Petri dish and stored in 1 L of enriched
media. These samples were processed as described in the DNA
sequencing section and utilized for both – MALDI-TOF MS iden-
tiﬁcation and PCR with subsequent sequencing.
MALDI-TOF  MS  identiﬁcation  of  bacteria
The following extraction protocol was based on MALDI
BiotyperTM 3.0 User Manual Revision 2, also used in a previ-
ous report.36 500 L of bacterial culture, cultivated overnight,
was centrifuged at 14,000 × g for 2 min. The supernatant
was discarded and the pellet was re-suspended in 300 L
of deionized water besides adding 900 L of ethanol. After
centrifugation at 14,000 × g for 2 min, the supernatant was
discarded and the obtained pellet was air-dried. The pellet
was then dissolved in 25 L of 70% formic acid (v/v) and 25 L
of acetonitrile and mixed. The samples were centrifuged at
14,000 × g for 2 min  and 1 L of the clear supernatant was
spotted in duplicate onto the MALDI target and air-dried at
room temperature. Then, each spot was overlaid with 1 L
of -cyano-4-hydroxycinnamic acid (HCCA) matrix solution
(20 mg  mL−1) in organic solvent (50% acetonitrile and 2.5% tri-
ﬂuoroacetic acid, both v/v) and air-dried completely prior to
MALDI-TOF MS measurement on UltraﬂeXtreme MS  (Bruker
Daltonik GmbH, Bremen, Germany). As matrix solution 2,5-
dihydroxybenzoic acid (DHB) was also used in the same
concentration and solvent as HCCA. Spectral data were taken
in the m/z range of 2000–30,000 Da, resulted from the accumu-
lation of 240 laser shots targeted to different regions of the
same sample spot. These data were analyzed with the Flex
Analysis software (Version 3.4). Final preparation of dendro-
grams was carried out in the MALDI BioTyperTM 3.1 (Bruker
Daltonik GmbH, Bremen, Germany).
DNA  sequencingBacterial cells were centrifuged at 4450 × g and 20 ◦C for
10 min. The pellet was resuspended in 400 L of lysis buffer
(6 M guanidium hydrochloride, 0.1 M sodium acetate) and cells 1 5;1  9(6):604–613
were lysed for 1 hour at 20 ◦C and 600 rpm on Multi RS-
60 (Biosan, Riga, Latvia). Genomic DNA was isolated from
lysed bacterial cultures via MagNA Pure Compact (Roche,
Mannheim, Germany), using Nucleic Acid Isolation Kit I, pro-
tocol DNA Bacteria.
16S rRNA gene was ampliﬁed using Taq PCR Mix
(New England Biolabs, Ipswich, MA, USA) and MasterCycler
realplex4 epgradient S (Eppendorf, Hamburg, Germany). 100 L
of reaction mixture consisted of: 1× Standard Taq Reaction
Buffer, 1.6 U of Taq DNA polymerase, 200 M Deoxynucleotide
Solution Mix, 0.5 M primers and 5 L of isolated genomic
DNA. The forward primer E9F 5′-GAGTTTGATCCTGGCTCAG-
3′ and reverse primer U1510R 5′-GGTTACCTTGTTACGACTT-3′
were synthesized by Sigma–Aldrich (St. Louis, MO, USA). The
reaction proﬁle was as follows: initial denaturation at 94 ◦C
for 4 min; 30 cycles of denaturation at 94 ◦C for 30 s, annealing
at 52 ◦C for 30 s and elongation at 72 ◦C for 105 s; with termi-
nal elongation at 72 ◦C for 10 min. Ampliﬁed fragments were
puriﬁed using MinElute PCR Puriﬁcation Kit (Qiagen, Hilden,
Germany).
For sequencing reaction the DTCS Quick Start Kit  (Beckman
Coulter, Pasadena, CA, USA) was used. To 20 L sequencing
reaction mixture, 98 ng of puriﬁed fragment, 0.75 L of 10 M
forward primer, 4 L of DTCS Quick Start Master Mix  and 1 L
of Sequencing Buffer were added. The conditions of 30 cycle-
reactions were as follows: 96 ◦C for 20 s; 50 ◦C for 20 s and 60 ◦C
for 4 min. The puriﬁcation of sequencing product was carried
out using CleanSEQ kit (Beckman Coulter). Puriﬁed samples
in Sample Loading Solution were transferred to the plate and
DNA sequencing was performed using Genetic Analysis Sys-
tem CEQ 8000 (Beckman Coulter). After denaturation at 90 ◦C
for 2 min, a ﬂuorescence-marked DNA fragments were sepa-
rated in 33 cm long capillary with 75 m i.d. (Beckman Coulter)
ﬁlled with linear polyacrylamide denaturing gel. The separa-
tion was run at capillary temperature of 50 ◦C and voltage of
4.0 kV for 85 min. Sequences were identiﬁed by comparison
with NCBI database.
Ampliﬁcation  of  S.  aureus  genes  mecA  and  fnbA
Isolation of genomic DNA was performed using the same
method as described in section DNA sequencing. The mecA and
fnbA genes were ampliﬁed using polymerase chain reaction
(PCR) as previously reported.37 The primers were synthesized
by Sigma-Aldrich and the sequences of forward and reverse
primers for mecA gene were 5′-CCCAATTTGTCTGCCAGTTT-3′,
and 5′-TGGCAATATTAACGCACCTC-3′ and for fnbA gene were
5′-GATACAAACCCAGGTGGTGG-3′, and 5′-TGTGCTTGACCAT-
GCTCTTC-3′. The volume of PCR reaction mixture was 100 L
containing 1× Taq reaction buffer, 0.2 mM dNTP, 1.6 U of Taq
DNA polymerase (New England Biolabs) and 0.5 mM of each
primer. The reaction proﬁle was as follows: initial denatur-
ation at 94 ◦C for 4 min, 30 cycles of denaturation at 94 ◦C for
30 s, annealing at 53 ◦C for 30 s and extension at 72 ◦C for 1 min
with a ﬁnal extension of 7 min. The ampliﬁcation generated a
223 bp for mecA and 191 bp for fnbA.Agarose gel (2% (v/v), high melt, Mercury, San Diego, CA,
USA) was prepared with 1× TAE buffer (40 mM Tris, 20 mM
acetic acid and 1 mM ethylenediaminetetraacetic acid) and
ethidium bromide (5 L per 100 mL  of the gel) as described
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lsewhere.38 100 bp DNA ladder (New England Biolabs) within
he size range from 100 to 1517 bp was used to monitor the
ize of the analyzed fragment. The electrophoresis (Bio-Rad,
ercules, CA, USA) was run at 60 V and 6 ◦C for 160 min.
he bands were visualized by UV transilluminator at 312 nm
Vilber-Lourmant, Marne-la-Vallée, France).
tatistical  processing  of  obtained  results
utomated neuronal network was used as a predictive model.
lassiﬁcation analysis automated neuronal network was used
or the estimation of categorical data. The dataset was ran-
omly divided as follows: 80% for learning, 10% for testing,
nd 10% for validation. Following network types were tested
sing automated network search: multilayer perceptron net-
ork (MLP), and radial basis function (RBF). Number of hidden
nits to search was determined as follows: 8–24 and 8–11 for
LP and RBF, respectively. Total 1000 networks were trained,
nd activation functions were searched for identity, logistic,
anh, exponential. Weight decay of 0.0001–0.001 was used for
idden layer and output layer. Weight of input variables for
earning was used based on MALDI-TOF classiﬁcation score.
nless noted otherwise, p-value less than 0.05 was considered
igniﬁcant. Software Statistica 12 (StatSoft, CA, USA) was used
or analysis.
esults  and  discussion
e  decided to employ a variety of cultivation approaches (in
resence of O2, CO2 or in microaerophilic conditions) to reveal
he presence of real microbiota associated with superﬁcial
nfections.
MALDI-TOF MS  was explored as an accurate and rapid
dentiﬁcation tool, using the protein mass patterns, which
re compared with patterns from a commercial Bruker Dal-
onics database (BDAL) of MALDI BiotyperTM software.39 Due
o a powerful software support, the method can be used
or identiﬁcation within few minutes, which is one of the
dvantages.36 Moreover, sequencing of ampliﬁed 16S rRNA
ene40 was employed for identiﬁcation independent of pro-
ein patterns. Finally, an artiﬁcial neural network (ANN) was
eveloped as a predictive model for evaluation of infection
everity and using developed ANN we  attempted to ﬁnd the
elationship between disease severity and the microorgan-
sms identiﬁed in clinical specimens.
dentiﬁcation  of  bacterial  strains  by  MALDI-TOF  MS  and
anger  sequencing
or the identiﬁcation of bacterial entities we employed com-
lementary methods for independent evaluation of different
iomolecules – proteins and DNA.36,41,42 Sanger sequencing
as utilized as a conﬁrmation method, based on sequenc-
ng of 16S rRNA gene. This gene contains hypervariable
egions, providing species-speciﬁc sequences, hence it can
rovide enough information for a conﬁdent discrimination,
nd thus became popular in medical microbiology to classify
acteria.43,445;1 9(6):604–613 607
When compared to sequencing, MALDI-TOF MS  offers
much shorter analysis time. By using this technique, wound
microbiome could be discriminated within one hour of incu-
bation, and thus this will likely become the method of choice
for future microbiome identiﬁcation. Nevertheless, the clas-
siﬁcation is based on a still developing database34; hence
MALDI-TOF MS identiﬁcation of non-databased bacteria has
still to be connected with other conﬁrmation methods. From
this reason we  ﬁrstly employed MALDI-TOF MS with a condi-
tion: If score <2.00 = 16S rRNA sequencing.
As shown in S2, 108 bacterial strains were identiﬁed37
of them had to be conﬁrmed by sequencing and conﬁrmed
strains were immediately databased to increase future clas-
siﬁcation success. Strains of S. aureus were the most often
identiﬁed (n = 35). Thus, methicillin-resistant S. aureus (MRSA)
is highly associated with severe infections in post-surgical
wounds45; we  further analyzed the mecA gene, encoding a
modiﬁed penicillin binding protein (PBP) known as PBP2a,
with decreased afﬁnity toward -lactams.46 The mecA posi-
tivity was determined in four isolates. Since 67% of patients
had deep wound infections and were treated for more  than
8 weeks after admission to infectious Department of Trauma
Hospital of Brno, presence of mecA was shown to be a crucial
microbiological factor, affecting patients prognosis. Further,
we determined the presence of fnbA gene, responsible for
adhesins production. Adhesion to human extracellular matrix
components and serum proteins is an important facet in
the interaction between bacteria and its host cells.47 Lim
and coworkers identiﬁed the presence of fnbA in 96% of
all isolated MRSA strains.35 In our case, fnbA presence was
conﬁrmed in all MRSA isolates and in 89% of methicillin-
sensitive S. aureus isolates. Similarly to mecA, fnbA was found
to be associated with infection severity. In patients with neg-
ative fnbA and mecA the treatment duration was less than
four weeks in 75% of cases, despite the fact that patients
had deep wound infections. This ﬁnding suggests that the
severity of staphylococcal infections does not depend solely
on antimicrobial resistance, but also on adhesins expres-
sion, which enhance the interaction with the target host
cells.
Distribution  of  identiﬁed  strains  within  various  cohorts  of
patients
According to duration of treatment, the patients were divided
into speciﬁc subgroups, where each sector represents one bac-
terial strain.
The subdivision of patients was based on surgical wounds
classiﬁcation SSI. As shown, patients were divided into two
groups - deep and superﬁcial wounds and the associated bac-
terial strains are depicted in Fig. 1A and B.
As it is obvious from Fig. 1A, in the more  serious infec-
tions (deep) S. aureus was the main bacterium of microbiome
composition (28% of identiﬁed strains), followed by Entero-
coccus faecalis (15%), and Escherichia coli (11%). On the other
hand, E. coli was not so often identiﬁed in surﬁcial wounds
(5% – Fig. 1B). Taken together, the microbiome composition
in both groups exhibits substantial differences, and thus it
can be hypothesized that presence of minority representatives
as Hafnia alvei, Proteus vulgaris, Staphylococcus lugdunensis, or
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Fig. 1 – Representation of microorganism species present in patients’ wounds. Patients were  grouped based on infection
severity. The graphs show bacterial cultures grown on different selective nutrient media. (A) Infection severity – deep
wounds and (B) infection severity – superﬁcial wounds.
Enterobacter cloacae in the wound can signiﬁcantly inﬂuence
the infection severity. It can be also stated that increasing
duration of treatment leads to increased number of identiﬁed
Enterobacteriaceae and opportunistic pathogens (Pseudomonas,
Enterococcus).
Phylogenetic  analysis  of  protein  alterations
48As was shown by Rettinger and colleagues, MALDI-TOF mass
spectra-based phylogenetic analysis is considered equivalent
to 16S rRNA gene sequencing. Therefore, we  employed MALDI
BiotyperTM for preparation of dendrograms for our groups,divided by treatment duration (Fig. 2). Dendrograms showed
similarity of same bacterial strains (low distance level), but in
some cases larger differences were found – usually among bac-
terial strains from different patients. These differences were
caused probably by modiﬁcations of bacterial proteins. Karger
et al. found methylation as a cause of higher distance level
in dendrogram between Burkholderia pseudomallei and other
types of B. pseudomallei.49 Thus it can be concluded that not
only changes in microbiome representatives affect treatment
duration and success, but also small changes in protein post-
translation modiﬁcations can be highly important for patients’
recovery.
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Fig. 2 – Dendrograms from protein mass proﬁles of microorganisms in different groups based on treatment duration.
Created in MALDI BiotyperTM. (A) Treatment duration less than four weeks. (B) Treatment duration 4–7 weeks. (C) Treatment
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rtiﬁcial  neural  network
wo neuronal networks were created: (1) for the predic-
ion of time-to-heal, and (2) for the prediction of infection
everity. The following input parameters were used for the
onstruction of networks: from 2000 networks ﬁve were
etained and one was used for further ﬁnal custom neu-
onal network. The settings of the network created using
utomated algorithm and used for the custom ﬁnal learn-
ng were Multilayer perceptron 89-13-3 (input-hidden-output
eurons), Broyden–Fletcher–Goldfarb–Shanno (BFGS) training
lgorithm, sum of squares error function, identity function for
idden layer, and then for output layer. The design of the net-
ork is displayed in Fig. 3A. With stopping conditions enabled
Fig. 3B), a ﬁnal network was created in the 17th training cycle
ith performances of 91.4%, 85.7%, and 71.4% for training,
Table 1 – Characterization of neuronal network performance for
in % for training, testing, and validation samples. The number 
in training algorithm column. BFGS, Broyden–Fletcher–Goldfarb
Prediction target Net. name Performance 
Training Testing Validatio
Infection severity MLP 89-19-2 100.00 85.71 85.71
Time-to-heal MLP 89-13-3 91.43 85.71 71.43testing, and validation (accuracy in prediction up to 85% –
Fig. 3C), respectively.
Consequently, a second neuronal network for the predic-
tion of infection severity was created using an automated
algorithm. The best-performing network was trained under
following settings: multilayer perceptron 89-19-2 (input-
hidden-output neurons) (Fig. 3D) BFGS training algorithm,
cross entropy error function, and exponential and softmax
activation function for hidden and output layer. The training
process is depicted in Fig. 3E (accuracy in prediction up to 85%
– Fig. 3F).
The performances of the network were 100.0%, 85.7%, and
85.7% for training, testing, and validation (Table 1), respec-
tively. The accuracy for individual cases is displayed in Table 2.
Sensitivity analysis of input variables for both networks
was carried out. For the prediction of infection severity,
 the prediction of patient outcome. Performance displayed
of training cycle for custom network training is displayed
–Shanno training algorithm; SOS, sum of squares.
Training
algorithm
Error
function
Activation
n Train
 BFGS 24 Infection severity MLP 89-19-2 100.00
 BFGS 17 Time-to-heal MLP 89-13-3 91.43
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Fig. 3 – Design and performance of the neuronal networks. (A) Design of classiﬁcation network for the prediction of
time-to-heal. The number of neurons/inputs is indicated by n. *Note the number of input and hidden neurons is not
displayed exactly. (B) Training process of the classiﬁcation network with stopping conditions activated. (C) Accuracy of the
ﬁnal network for classiﬁcation of time-to-heal. (D) Design of classiﬁcation network for the prediction of infection severity. (E)
Training process for creation of this network with stopping criteria activated. (F) Accuracy of the network for the prediction
of infection severity.
Table 2 – Performance of the network: veriﬁcation of the test and validation cohort. Analysis for both networks for
prediction of infection severity and time-to-heal. Test cohort was employed for stopping conditions. Validation sample
was used to test ﬁnal network. “target” indicates input data, network output reﬂects calculated result from the neuronal
network. id, identiﬁcation of patient; w,  week.
Sample ID Case weights Infection severity Time-to-heal
Target Network output Accuracy Conf. level Target Network output Accuracy Conf. level
Test 2  1.71 Superﬁcial Superﬁcial Correct 1.00 <4 w <4 w Correct 0.40
6 1.81 Deep Deep Correct 1.00 >8 w <4 w Incorrect 0.47
8 1.65 Superﬁcial Superﬁcial Correct 1.00 <4 w <4 w Correct 0.36
22 2.00 Superﬁcial Superﬁcial Correct 1.00 >8 w >8 w Correct 0.41
38 2.06 Deep Superﬁcial Incorrect 1.00 <4 w <4 w Correct 0.49
39 2.01 Deep Deep Correct 1.00 <4 w <4 w Correct 0.56
40 2.12 Superﬁcial Superﬁcial Correct 1.00 <4 w <4 w Correct 0.43
Validation 7 1.68 Superﬁcial Deep Incorrect 1.00 <4 w <4 w Correct 0.40
23 1.62 Superﬁcial Superﬁcial Correct 1.00 >8 w >8 w Correct 0.49
27 2.23 Deep Deep Correct 0.87 4–7 w <4 w Incorrect 0.58
28 2.11 Superﬁcial Superﬁcial Correct 1.00 <4 w <4 w Correct 0.47
36 2.27 Deep Deep Correct 1.00 4–7 w 4–7 w Correct 0.63
45 1.88 Deep Deep Correct 1.00 <4 w <4 w Correct 0.43
49 2.25 Deep Deep Correct 1.00 4–7 w <4 w Incorrect 0.56
b r a z j i n f e c t d i s . 2 0 1 5;1 9(6):604–613 611
age
0%
Alzheimer
0%
paresis/plegia
0%
Staph ylo cocc us 
haemolyticus
0%
S. aur eus 2 mec A 
gene
1%
Enterob cter cl a ae
1%
Neisseria mucos a
1%Proteus vulgaris
1% Streptococcus  
agalactiae
1%
Steno tro phom onas 
maltopili a
1%
Acinetobacte r 
genomospec.
1%
ICHS
1%
Shigella flexneri
1%
p ptic ulcer
1%
Hafni a alve i
1%
Klebsiella
pneumonia e
1%
Acinetobacte r 
bauman nii
1%
S. aureus 2 fnbA gene
2%Staphylococcus 
aureus
2%Staphylococcus 
epidermidis
2%Staphylococcus 
lugdunensis
2%
DM
3%
osteomyelitis
3%
main diagno sis
3%
Corynebacterium  
striatum
3%
Pseudo monas 
aeruginosa
3%
Parkinson
4%
revmatoid
4%Pseudo monas 
mendocin a
4%
Staph ylo cocc us 
cohnii
5%
Acinet obacter lw offi i
5%
gender
5%
Enterococcus faecalis
5%
Escherichia col i
5%
obesity
6%
ulcerous colitis
9%
hyperten sion
11%
Steno tro phom onas 
maltopili a
2%
C rynebacterium  
striatum
2%
Streptococcus 
agalactiae
2%Neisseria mucos a
2%
Acinetobacter 
genomospec.
2%
S. aureus 1 fnbA gene
2%Enterobacter cloacae
2%
Acinetobacter
bauman nii
2%
Staphylococcus 
aureus
2%age
2%
Acinetobacter lwoffii
2%
S. aureus 1 mecA 
gene
2%Staphylococcus 
lugdunensis
2%Klebsiella
pneumonia e
2%
Ente roco ccus faecal is
2%
Hafnia alve i
2%
Staphylococcus 
cohnii
2%
S. aureu s 2 mec A 
gene
2%
ICHS
2%
Proteus  vulgar is
2%
S. aureus 2 fnbA gene
2%
DM
2%revmatoid2%
obesity
3%
peptic ulcer
3%
Shigella flexneri
3%
Escherichia coli
3%
main diagnosis
3%
paresis/plegia
3%
Staph ylo cocc us 
epidermidis
3%
hypertension
3%
Pseudo monas 
aeruginosa
3%
gender
3%
Alzheimer
3%
Staphylococcus 
haemolyticus
4%
Pseudomonas 
mendocin a
4%
osteomyelitis
4%
Parkinson
4%
ulcerous coliti s
4%
A B
Fig. 4 – Sensitivity analysis of all factors for prediction of time-to-heal and infection severity. Sensitivity of individual factors
depicted as a percentage of total sensitivity. (A) Sensitivity of individual factors for the prediction of time-to-heal. (B)
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rensitivity of individual factors for the prediction of infectio
he mean sensitivity level was 4.66, ranging from 0.63 to
0.1, and a total sensitivity = 179.9 (Fig. 4) The highest level
f sensitivity (thus highest impact on prediction of a net-
ork) was observed for hypertension (20.15), ulcerative colitis
17.06), obesity (10.13), E. coli (8.87), E. faecalis (8.50), and other
actors. The factors with sensitivity <1 were P. vulgaris, Neis-
eria mucosa, E. cloacae,  S. aureus 2 mecA genes, Staphylococcus
aemolyticus, paresis/plegia, Alzheimer’s disease, age.
For the prediction of time-to-heal, the sensitivity was dis-
inctly more  homogeneous for the input factors with mean
ensitivity = 1.35, (0.99–2.35), total sensitivity = 52.49. The fac-
ors with higher sensitivity included ulcerative colitis (2.35),
arkinson’s disease (2.27), osteomyelitis (2.15), Pseudomonas
endocina (2.11), S. haemolyticus (1.84) and others (Fig. 4). The
actors with sensitivity <1 include Streptococcus agalactiae,
orynebacterium striatum, and Stenotrophomonas maltopilia.
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